Interleukin-12 is critical for induction of nitric oxide-mediated immunosuppression following vaccination of mice with attenuated Salmonella typhimurium

Infection and Immunity

Volumn 65, Issue 12, 1997, Pages 4897-4903

  Schwacha, Martin G ^a,b   Eisenstein, Toby K ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INOCULATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SPLEEN CELL; VACCINATION;

EID: 0030780577     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.12.4897-4903.1997     Document Type: Article

References (76)

1. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235-237.
2. Aida, Y., and M. J. Pabst. 1990. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J. Immunol. Methods 132:191-195.
3. Albina, J. E., J. A. Abate, and W. L. Henry, Jr. 1991. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogenstimulated T cell proliferation. Role of IFN-γ in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147:144-148.
4. Al-Ramadi, B. K., M. A. Brodkin, D. M. Mosser, and T. K. Eisenstein. 1991. Immunosuppression induced by attenuated Salmonella. Evidence for mediation by macrophage precursors, J. Immunol. 146:2737-2746.
5. Al-Ramadi, B. K., J. M. Greene, J. J. Meissler, Jr., and T. K. Eisenstein. 1992. Immunosuppression induced by attenuated Salmonella: effect of LPS responsiveness on development of suppression. Microb. Pathog. 12:267-278.
6. Al-Ramadi, B. K., J. J. Meissler, Jr., D. Huang, and T. K. Eisenstein. 1992. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur. J. Immunol. 22:2249-2254.
7. Boockvar, K. S., D. L. Granger, R. M. Poston, M. Maybodi, M. K. Washington, J. B. Hibbs, and R. L. Kurlander. 1994. Nitric oxide produced during murine listeriosis is protective. Infect. Immun. 62:1089-1100.
8. Brunda, M. J. 1994. Interleukin-12. J. Leukocyte Biol. 55:280-288.
9. Candolfi, E., C. A. Hunter, and J. S. Remington. 1994. Mitogen- and antigenspecific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infect. Immun. 62:1995-2001.
10. Car, B. D., V. M. Eng, B. Schnyder, M. Lehir, A. N. Shakhov, G. Woerly, S. Huang, M. Aguet, T. D. Anderson, and B. Ryffel. 1996 Role of interferon-γ in interleukin 12-induced pathology in mice. Am. J. Pathol. 147:1643-1707.
11. Chan, S. H., B. Perussia. J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf. D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responding cells and synergy with other inducers. J. Exp. Med. 173:864-879.
12. Chong, C., K. L. Bost, and J. D. Clements. 1996. Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp. Infect. Immun. 64:1154-1160.
13. Cunningham, A., and A. Szenberg. 1468. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology 14:544-600.
14. Ding, D. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
15. Eisenstein, T. K. 1444. Suppressor macrophages, p. 203-224. In B. S. Zwilling and T. K. Eisenstein (ed.), Macrophage-pathogen interactions. Marcel Dekker, Inc., New York, N.Y.
16. Eisenstein, T. K., B. Bushnell, J. J. Meissler, N. Dalal, R. Schafer, and H. F. Havas. 1996. Immunotherapy of a plasmacytoma with attenuated salmonella. Med. Oncol. 12:103-108.
17. Eisenstein, T. K., N. Dalal, L. Killar, J. C. Lee, and R. Schafer. 1988. Paradoxes of immunity and immunosuppression in Salmonella infection. Adv. Exp. Med. Biol. 239:353-366.
18. Eisenstein, T. K., D. Huang, J. J. Meissler, Jr., and B. K. Al-Ramadi. 1994. Macrophage nitric oxide mediates immunosuppression in infectious inflammation. Immunobiology 191:493-502.
19. Eisenstein. T. K., L. M. Killar, B. A. D. Stocker, and B. M. Sultzer. 1484. Cellular immunity induced by avirulent Salmonella in LPS-defective C3H/ HeJ mice. J. Immunol. 133:958-961.
20. Flesch, I. E. A., J. H. Hess, S. Huang, M. Aguet, J. Rothe, H. Bluemann, and S. H. E. Kaufmann. 1995. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J. Exp. Med. 181:1615-1621.
21. Flynn, J. L., M. M. Goldstein. K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515-2524.
22. Fujiwara, H., J. P. Zou, S. Herrmann, and T. Hamaoka. 1995, A sequence of cellular and molecular events involved in IL-12-induced tumour regression. Res. Immunol. 146:638-644.
23. Germann, T., J. Szeliga, H. Hess, S. Storkel, F. J. Podlaski, M. K. Gately, E. Schmitt, and E. Rude. 1995. Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA 92:4823-4827.
24. Hall, S. S. 1995. IL-12 at the crossroads. Science 268:1432-1432.
25. Heinzel, F. P., R. M. Rerko, F. Ahmed, and A. M. Hujer. 1996. IFN-γindependent production of IL-12 during murine endotoxemia. J. Immunol. 157:4521-4528.
26. Heinzel, F. P., R. M. Rerko, P. Ling, J. Hakimi, and D. S. Schoenhaut. 1994. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect. Immun. 62:4244-4249.
27. Hibbs, J.B., Jr., R. R. Taintor, Z. Vavrin, and E. M. Rachlin. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:87-94.
28. Hoiseth, S. K., and B. A. D. Stocker, 1981, Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
29. Hormaeche, C. E., K. A. Harrington, and H. S. Joysey. 1985. Natural resistance to salmonellae in mice: control by genes within the major histocompatibility complex. J. Infect. Dis. 152:1050-1056.
30. Huang, D., M. G. Schwacha, and T. K. Eisenstein. 1996, Attenuated salmonella vaccine-induced suppression of murine spleen cell responses to mitogen is mediated by macrophage nitric oxide: quantitative aspects. Infect. Immun. 64:3786-3792.
31. Huang, D., M. G. Schwacha. J. J. Meissler, Jr., G. Yumet, K. J. Soprano, F. Sutterwala, D. M. Mosser, and T. K. Eisenstein. Precursor macrophages in spleens of Salmonella-infected mice are induced by IFN-γ to make nitric oxide and to be immunosuppressive. Submitted for publication.
32. Huang, F. P., G. J. Feng. G. Lindop, D. I. Stott, and F. Y. Liew. 1996. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-Ipr/lpr mice. J. Exp. Med. 183:1447-1459.
33. Hunter, C. A., E. Candolfi, C. Subauste, V. Van Cleave, and J. S. Remington. 1995. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84:16-20.
34. Hunter, C. A., R. Chizzonite, and J. S. Remington, 1995. IL-1β is required for IL-12 to induce production of IFN-γ by NK cells. A role for IL-1β in the T cell independent mechanism of resistance against intracellular pathogens. J. Immunol. 155:4347-4354.
35. Kilbourn, R., and G. Lopez-Berestein. 1990. Protease inhibitors block the macrophage-mediated inhibition of tumor cell mitochondrial respiration. J. Immunol. 144:1042-1045.
36. Killar, L. M., and T. K. Eisenstein. 1984. Differences in delayed-type hyper-sensitivity responses in various mouse strains in the C3H lineage infect with Salmonella typhimurium strain SL3235. J. Immunol. 133:1190-1196.
37. Killar, L. M., and T. K. Eisenstein. 1985. Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCr1BR mice: studies with an aromatic-dependent live S. typhinmrium strain as a vaccine. Infect. Immun. 47:605-612.
38. Killar, L., and T. K. Eisenstein. 1986. Delayed-type hypersensitivity and immunity to Salmonella typhimurium. Infect. Immun. 52:504-508.
39. Kincycain, T., J. D. Clements, and K. L. Bost. 1996. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect. Immun. 64:1437-1440.
40. Kobayashi. M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. London, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med, 170:827-839.
41. Kwon, N. S., D. J. Stuehr, and C. F. Nathan. 1991. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 174:761-767.
42. Lee, J.-C., C. W. Gibson, and T. K. Eisenstein. 1985, Macrophage-mediated mitogenic suppression induced in mice of the C3H lineage by a vaccine strain of Salmonella typhimunrium. Cell. Immunol. 91:75-91.
43. Leonard, J. P., K. E. Waldburger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12. J. Exp. Med. 181:381-386.
44. Lepoivre, M., J. M. Flaman, P. Bobe, G. Lemaire, and Y. Henry. 1994. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages. J. Biol. Chem. 269:21891-21897.
45. Locksley, R. M. 1993. Interleukin 12 in host defense against microbial pathogens. Proc. Natl. Acad. Sci. USA 90:5879-5880.
46. Lorsbach, R. B., W. J. Murphy, C. J. Lowenstein, S. H. Snyder, and S. W. Russel. 1993. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between Interferon-γ and lipopolysaccharide. J. Biol. Chem. 268:1908-1913.
47. MacMicking, J., Q.-W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
48. Mastroeni, P., J. A. Harrison, J. A. Chabalgoity, and C. E. Hormaeche. 1996. Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Infect. Immun. 64:189-196.
49. 48a.Mishell, R. I., and R. W. Duttow. 1967. Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 126:423-442.
50. Muotiala, A., and P. H. Makela. 1993. Role of gamma interferon in late stages of murine salmonellosis. Infect. Immun. 61:4248-4253.
51. Nastala. C. L., H- D. Edington, T. G. McKinney, H. Tahara, M. A. Nalesnick, M. Brunda, M. K. Gately, S. F. Wolf, R. D. Schreiber, W. J. Storkus, and M. T. Lotze. 1994. Recomhinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153:1697-1713.
52. Nuclei, C., F. Vilde, and E. Ronco. 1985. Host response to infection with a temperature-sensitive mutant of Salmonella typhimurium in a susceptible and a resistant strain of mice. Infect. Immun. 49:523-527.
53. Ramarathinam, L., D. W. Niesel, and G. R. Klimpel. 1993. Salmonella typhimurium induces IFN-γ production in murine splenocytes. Role of natural killer cells and macrophages. J. Immunol. 150:3973-3981.
54. Ramarathinam, L., R. A. Shaban, D. W. Niesel, and G. R. Klimpel. 1991. IFN-γ production by gut-associated lymphoid tissue and spleen following oral S. typhimurium challenge. Microb. Pathog. 11:347-352.
55. Rao, J. B., R. S. Chamberlain, V. Bronte, M. W. Carroll, K. R. lrvine, B. Moss, S. A. Rosenberg, and N. P. Restifo. 1996, IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines. J. Immunol. 156:3357-3365.
56. Saunders, B- A., Y. Zhan, and C. Cheers. 1995, Endogenous interleukin-12 is involved in resistance of mice to Mycobaeterium avium complex infection. Infect. Immun, 63:4011-4015.
57. Schafer, R., and T. K. Eisenstein. 1992. Natural killer cells mediate protection induced by a Salmonella aroA mutant. Infect. Immun. 60:791-797.
58. Schafer, R., C. A. Nacy, and T. K. Eisenstein. 1988. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella, J. Immunol. 140: 1638-1644.
59. Scharton-Kersten, T., L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320-5330.
60. Scharton-Kersten, T. M., G. Yap, J. Magram, and A. Sher. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1261-1273.
61. Schwacha, M. G., and T. K. Eisenstein. 1995. Murine splenocyte nitric oxide production following Salmonella typhimurium infection is regulated by natural killer cells and interferon-γ. J. Leukocyte Biol. 57(Suppl.):18.
62. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induction of interferon γ-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700-10702.
63. Sternberg, J., and F. McGuigan. 1992. Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection. Eur. J. Immunol. 22:2741-2744.
64. Stevenson, M. M., M. F. Tam, S. F. Wolf, and A. Sher. 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155:2545-2556.
65. Takagi, K., I. Nukaya, K. Yasukawa, and S. Yasunobu. 1994. Inhibitory mechanisms of antibody production by nitrogen oxides released from activated macrophages during the immune response: Relationship to energy consumption. Immunobiol. Cell. Biol. 72:241-248.
66. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M. K. Gately, and L. Adorini. 1995. Interleukin-12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817-821.
67. Trinchieri, G., and F. Gerosa. 1996. Immunoregulation by interleukin-12. J. Leukocyte Biol. 59:505-511.
68. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B.-17 mice. J. Immunol. 152:1883-1887.
69. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor-α are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90: 3725-3792.
70. Wigginton, J. M., D. B. Kuhns, T. C. Back, M. J. Brunda, R. H. Wiltrout, and G. W. Cox. 1996. Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2. Cancer Res. 56:1131-1136.
71. Wu, L., P. S. Morahan, J. A. Hendrzak, and T. K. Eisenstein. 1994. Herpes simplex virus type 1 replication and IL-1β gene expression in mouse peritoneal macrophages activated in vivo by an attenuated Salmonella typhimurium vaccine or Cotynebacterium parvum. Microb. Pathog. 16:387-399.
72. Wynn, T. A., A. Reynolds, S. James, A. W. Cheever, P. Caspar, S. Hieny, D. Jankovic, M. Strand, and A. Sher 1996. IL-12 enhances vaccine-induced immunity to Schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J. Immunol. 157:4068-4078.
73. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta. P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25: 672-670.
74. Zhan, Y., and C. Cheers. 1995 Endogenous interleukin-12 is involved in resistance to Brncella abortus infection. Infect. Immun. 63:1387-1390.
75. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, R. T. Gazzinelli, A. Sher, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J. Immunol. 155:785-795.
76. Zidek, Z., E. Lotzova, D. Frankova, and C. A. Savary. 1996. Indirect stimulatory effects of murine interleukin-12 on in vitro production of nitric oxide by mouse peritoneal cells. J. Interferon Cytokine Res. 16:389-393.